Business
Currency:CNY
2024/FY
Stock NameRevenueRatio
授权协议收入100.94M63.57%
提供研发服务及其他服务的收入55.71M35.08%
Sale of drugs2.14M1.35%
Product
Currency:CNY
2024/FY
Stock NameRevenueRatio
授权协议收入100.94M63.57%
提供研发服务及其他服务的收入55.71M35.08%
Sale of drugs2.14M1.35%
Region
Currency:CNY
2024/FY
Stock NameRevenueRatio
People's Republic of China158.79M100.00%